Exalt Model D
Payments companies reported to CMS as associated with Exalt Model D. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Exalt Model D, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Exalt Model D
These are the largest totals companies reported as associated with Exalt Model D. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Veeral Oza | Greenville, SC | Gastroenterology (Internal Medicine) | $81,716.17 |
| Venkataraman Muthusamy | Los Angeles, CA | Gastroenterology (Internal Medicine) | $58,647.21 |
| Jonh Pineda-Bonilla | Salem, VA | Gastroenterology (Internal Medicine) | $52,778.83 |
| Adarsh Thaker | Los Angeles, CA | Gastroenterology (Internal Medicine) | $49,249.53 |
| Sammy Ho | Bronx, NY | Gastroenterology (Internal Medicine) | $31,897.96 |
| Christopher Chapman | Chicago, IL | Gastroenterology (Internal Medicine) | $24,123.62 |
| Jeremy Barber | Grand Rapids, MI | Gastroenterology (Internal Medicine) | $20,123.99 |
| Neil Sharma | Gilbert, AZ | Gastroenterology (Internal Medicine) | $19,613.22 |
| Mark Gromski | Indianapolis, IN | Gastroenterology (Internal Medicine) | $18,472.78 |
| Nikhil Kumta | New York, NY | Gastroenterology (Internal Medicine) | $18,314.33 |
Prescribed Exalt Model D?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.